Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02861365 · ClinicalTrials.gov registry record
Myocardial Perfusion and Scarring in Adults With Congenital Heart Disease
A clinical trial, sponsored by Children's National Research Institute.
- Completed
- Registry status
- 18
- Enrollment target
NCT02861365: Completed study, sponsored by Children's National Research Institute.
NCT02861365 is a clinical trial that has completed, run by Children's National Research Institute. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02861365 has completed, sponsored by Children's National Research Institute.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is a study of the perfusion of the myocardium in adults with specific forms of repaired congenital heart disease using established cardiac MRI techniques and correlating perfusion with clinical outcomes.
Primary Outcome
Compare quantitative myocardial perfusion at stress and rest with measures of systolic and diastolic function in exams performed in close temporal proximity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-07 |
| Est. Completion | 2020-01-18 |
What the finished NCT02861365 record still lists
NCT02861365 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02861365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02861365 about?
NCT02861365 is a clinical study titled "Myocardial Perfusion and Scarring in Adults With Congenital Heart Disease". This is a study of the perfusion of the myocardium in adults with specific forms of repaired congenital heart disease using established cardiac MRI techniques and correlating perfusion with clinical outcomes.
What is the current status of trial NCT02861365?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2013-07. Estimated completion is 2020-01-18.
Who is sponsoring clinical trial NCT02861365?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia